Japan Cell and Gene Therapy Market Overview
Market Statistics
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 727 Million
Market Forecast in 2033: USD 2,016 Million
Market Growth Rate: 12% (2025-2033)
According to the latest report by IMARC Group, the Japan cell and gene therapy market size reached USD 727 million in 2024. Going forward, IMARC Group expects it to reach USD 2,016 million by 2033, exhibiting a CAGR of 12% from 2025 to 2033.
Download a Sample PDF of This Report: https://www.imarcgroup.com/japan-cell-gene-therapy-market/requestsample
Japan Cell and Gene Therapy Industry Trends and Drivers
The Japan cell and gene therapy market is expanding quickly due to the promising advancements in biotechnology, and growing investment in regenerative medicine. Depending upon the relevant amount of chronic diseases, including oncology and cardiovascular, there offers an opportunity for market expansion, with oncology disorders commanding a significant share of the market. The Government of Japan's favourable regulatory environment such as, the Act on the Safety of Regenerative Medicine has resulted in growing approvals and entry for regenerative medicine, specifically cell and gene therapies. The aging population and existing genetic and neurological disorders will provide significant opportunities for market growth. The in-vivo delivery modes are growing in acceptance due to the targeted approach and hospitals and cancer care centers account for the largest end user segments in cell and gene therapy markets. The pharmaceutical and biotechnology businesses are considerable investors in R&D, with partnerships being formed to develop the next generation of therapies. The Kanto region has the most developed healthcare systems in Japan, followed by Kinki and Chubu regions. The challenges that exist in the Japan cell and gene therapy market are high treatment costs, and the highly complex process to manufacture cell and gene therapeutics. Nevertheless, we are seeing rapid growth in medical tourism, while stem cell and gene-editing technologies are rapidly emerging as key catalysts for the Japan cell and gene therapy market.
Japan Cell and Gene Therapy Market Segmentation
The market report offers a comprehensive analysis of the segments, highlighting those with the largest Japan cell and gene therapy market share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments:
Analysis by Therapy Type:
Cell Therapy
- Stem Cell
- Non-Stem Cell
Gene Therapy
Analysis by Indication:
- Cardiovascular Disease
- Oncology Disorder
- Genetic Disorder
- Infectious Disease
- Neurological Disorder
- Others
Analysis by Delivery Mode:
- In-Vivo
- Ex-Vivo
Analysis by End User:
- Hospitals
- Cancer Care Centers
- Pharmaceutical and Biotechnology Companies
- Others
Regional Insights:
- Kanto Region
- Kinki Region
- Central/Chubu Region
- Kyushu-Okinawa Region
- Tohoku Region
- Chugoku Region
- Hokkaido Region
- Shikoku Region
Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=report&id=17931&flag=C
Competitive Landscape
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of all major companies in the Japan cell and gene therapy industry.
Other Key Points Covered in the Report:
- COVID-19 Impact on the Market
- Porter's Five Forces Analysis
- Strategic Recommendations
- Market Dynamics
- Historical, Current, and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
- Top Winning Strategies
- Recent Industry News
- Key Technological Trends & Development
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact:
Street: 563-13 Kamien
Area: Iwata
Country: Tokyo, Japan
Postal Code: 4380111
Em
ail: sales@imarcgroup.com